These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 31660989)

  • 1. Genetic relevance and determinants of mitral leaflet size in hypertrophic cardiomyopathy.
    Chung H; Kim Y; Park CH; Kim JY; Min PK; Yoon YW; Kim TH; Lee BK; Hong BK; Rim SJ; Kwon HM; Lee KA; Choi EY
    Cardiovasc Ultrasound; 2019 Oct; 17(1):21. PubMed ID: 31660989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular magnetic resonance of mitral valve length in hypertrophic cardiomyopathy.
    Tarkiainen M; Sipola P; Jalanko M; Heliö T; Laine M; Järvinen V; Häyrinen K; Lauerma K; Kuusisto J
    J Cardiovasc Magn Reson; 2016 Jun; 18(1):33. PubMed ID: 27259862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation between left ventricular outflow tract obstruction and left ventricular shape in patients with hypertrophic cardiomyopathy: a cardiac magnetic resonance imaging study.
    Martin R; Lairez O; Boudou N; Méjean S; Lhermusier T; Dumonteil N; Berry M; Cognet T; Massabuau P; Elbaz M; Rousseau H; Galinier M; Carrié D
    Arch Cardiovasc Dis; 2013; 106(8-9):440-7. PubMed ID: 23906680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy.
    Maron MS; Olivotto I; Harrigan C; Appelbaum E; Gibson CM; Lesser JR; Haas TS; Udelson JE; Manning WJ; Maron BJ
    Circulation; 2011 Jul; 124(1):40-7. PubMed ID: 21670234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal septal convexity into the left ventricle occurs in subclinical hypertrophic cardiomyopathy.
    Reant P; Captur G; Mirabel M; Nasis A; M Sado D; Maestrini V; Castelletti S; Manisty C; Herrey AS; Syrris P; Tome-Esteban M; Jenkins S; Elliott PM; McKenna WJ; Moon JC
    J Cardiovasc Magn Reson; 2015 Jul; 17(1):64. PubMed ID: 26219660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of mitral valve leaflet length and septal wall thickness to outflow tract obstruction in patients with hypertrophic cardiomyopathy.
    Morant K; Mikami Y; Nevis I; McCarty D; Stirrat J; Scholl D; Rajchl M; Giannoccaro P; Kolman L; Heydari B; Lydell C; Howarth A; Grant A; White JA
    Int J Cardiovasc Imaging; 2017 Aug; 33(8):1201-1211. PubMed ID: 28391581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of anterior mitral valve leaflet length in individuals with a hypertrophic cardiomyopathy gene mutation without hypertrophic changes.
    van Velzen HG; Schinkel AFL; Menting ME; van den Bosch AE; Michels M
    J Ultrasound; 2018 Sep; 21(3):217-224. PubMed ID: 29876904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal Mitral Valve Dimensions in Pediatric Patients with Hypertrophic Cardiomyopathy.
    Schantz D; Benson L; Windram J; Wong D; Dragulescu A; Yoo SJ; Mertens L; Friedberg M; Al Nafisi B; Grosse-Wortmann L
    Pediatr Cardiol; 2016 Apr; 37(4):784-8. PubMed ID: 26961572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systolic anterior motion of the anterior mitral valve leaflet begins in subclinical hypertrophic cardiomyopathy.
    Seitler S; De Zoysa Anthony S; Obianyo CCC; Syrris P; Patel V; Sado DM; Maestrini V; Castelletti S; Walsh S; O'Brien B; Moon JC; Captur G
    Eur Heart J Cardiovasc Imaging; 2023 Dec; 25(1):86-94. PubMed ID: 37523765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy Patients Without Severe Septal Hypertrophy: Implications of Mitral Valve and Papillary Muscle Abnormalities Assessed Using Cardiac Magnetic Resonance and Echocardiography.
    Patel P; Dhillon A; Popovic ZB; Smedira NG; Rizzo J; Thamilarasan M; Agler D; Lytle BW; Lever HM; Desai MY
    Circ Cardiovasc Imaging; 2015 Jul; 8(7):e003132. PubMed ID: 26082555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vector flow mapping in obstructive hypertrophic cardiomyopathy to assess the relationship of early systolic left ventricular flow and the mitral valve.
    Ro R; Halpern D; Sahn DJ; Homel P; Arabadjian M; Lopresto C; Sherrid MV
    J Am Coll Cardiol; 2014 Nov; 64(19):1984-95. PubMed ID: 25440093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular structure and diastolic function by cardiac magnetic resonance imaging in hypertrophic cardiomyopathy.
    Chacko BR; Karur GR; Connelly KA; Yan RT; Kirpalani A; Wald R; Jimenez-Juan L; Jacob JR; Deva DP; Yan AT
    Indian Heart J; 2018; 70(1):75-81. PubMed ID: 29455792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CMR assessment and clinical outcomes of hypertrophic cardiomyopathy with or without ventricular remodeling in the end-stage phase.
    Cheng S; Choe YH; Ota H; Cui C; Yin G; Lu M; Li L; Chen X; Prasad SK; Zhao S
    Int J Cardiovasc Imaging; 2018 Apr; 34(4):597-605. PubMed ID: 29071521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left Atrial structure and function in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.
    Farhad H; Seidelmann SB; Vigneault D; Abbasi SA; Yang E; Day SM; Colan SD; Russell MW; Towbin J; Sherrid MV; Canter CE; Shi L; Jerosch-Herold M; Bluemke DA; Ho C; Neilan TG
    J Cardiovasc Magn Reson; 2017 Dec; 19(1):107. PubMed ID: 29284499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incremental value of left atrial active function measured by speckle tracking echocardiography in patients with hypertrophic cardiomyopathy.
    Fujimoto K; Inoue K; Saito M; Higashi H; Kono T; Uetani T; Aono J; Nagai T; Nishimura K; Suzuki J; Okura T; Ikeda S; Nakatani S; Higaki J
    Echocardiography; 2018 Aug; 35(8):1138-1148. PubMed ID: 29648690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphological determinants of echocardiographic patterns of mitral valve systolic anterior motion in obstructive hypertrophic cardiomyopathy.
    Klues HG; Roberts WC; Maron BJ
    Circulation; 1993 May; 87(5):1570-9. PubMed ID: 8491013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Burden of Early Phenotypes and the Influence of Wall Thickness in Hypertrophic Cardiomyopathy Mutation Carriers: Findings From the HCMNet Study.
    Ho CY; Day SM; Colan SD; Russell MW; Towbin JA; Sherrid MV; Canter CE; Jefferies JL; Murphy AM; Cirino AL; Abraham TP; Taylor M; Mestroni L; Bluemke DA; Jarolim P; Shi L; Sleeper LA; Seidman CE; Orav EJ;
    JAMA Cardiol; 2017 Apr; 2(4):419-428. PubMed ID: 28241245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphological and functional abnormalities pattern in hypertrophy-free HCM mutation carriers detected with echocardiography.
    Peyrou J; Réant P; Reynaud A; Cornolle C; Dijos M; Rooryck-Thambo C; Landelle M; Montaudon M; Laurent F; Roudaut R; Lafitte S
    Int J Cardiovasc Imaging; 2016 Sep; 32(9):1379-1389. PubMed ID: 27324645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helical distribution of hypertrophy in patients with hypertrophic cardiomyopathy: prevalence and clinical implications.
    Viliani D; Pozo E; Aguirre N; Cecconi A; Olivera MJ; Caballero P; Jiménez-Borreguero LJ; Alfonso F
    Int J Cardiovasc Imaging; 2017 Nov; 33(11):1771-1780. PubMed ID: 28536896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early changes in apical rotation in genotype positive children with hypertrophic cardiomyopathy mutations without hypertrophic changes on two-dimensional imaging.
    Forsey J; Benson L; Rozenblyum E; Friedberg MK; Mertens L
    J Am Soc Echocardiogr; 2014 Feb; 27(2):215-21. PubMed ID: 24325958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.